Covered recipient · General Payments record
GREGORY A GRECO
Allopathic & Osteopathic Physicians Plastic Surgery
General Payments · PY2018–2024
$15,626.07
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,095.16 | 35 |
| Long term medical supply or device loan | $321.58 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $919.61 | 32 |
| Integra LifeSciences Corporation | $331.70 | 3 |
| Kerecis Limited | $147.78 | 1 |
| Mindray DS USA, Inc. | $17.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.95 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831898 | CMS |
| ABBVIE INC. | $25.75 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831900 | CMS |
| ABBVIE INC. | $15.57 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831902 | CMS |
| ABBVIE INC. | $10.98 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831904 | CMS |
| ABBVIE INC. | $19.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831906 | CMS |
| ABBVIE INC. | $24.81 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831908 | CMS |
| ABBVIE INC. | $7.08 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831910 | CMS |
| ABBVIE INC. | $9.08 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831912 | CMS |
| ABBVIE INC. | $69.27 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831914 | CMS |
| ABBVIE INC. | $18.75 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831916 | CMS |
| ABBVIE INC. | $7.73 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831918 | CMS |
| ABBVIE INC. | $2.01 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831920 | CMS |
| ABBVIE INC. | $169.10 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831922 | CMS |
| ABBVIE INC. | $18.65 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831924 | CMS |
| ABBVIE INC. | $9.27 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831926 | CMS |
| ABBVIE INC. | $25.67 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831928 | CMS |
| ABBVIE INC. | $8.44 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831930 | CMS |
| ABBVIE INC. | $23.86 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831932 | CMS |
| ABBVIE INC. | $10.75 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831934 | CMS |
| ABBVIE INC. | $2.54 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831936 | CMS |
| ABBVIE INC. | $137.31 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831938 | CMS |
| ABBVIE INC. | $14.12 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831940 | CMS |
| ABBVIE INC. | $25.72 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831942 | CMS |
| ABBVIE INC. | $6.46 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831944 | CMS |
| ABBVIE INC. | $22.81 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831946 | CMS |
| ABBVIE INC. | $123.82 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831948 | CMS |
| ABBVIE INC. | $27.84 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831950 | CMS |
| ABBVIE INC. | $8.53 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831952 | CMS |
| ABBVIE INC. | $3.09 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831954 | CMS |
| ABBVIE INC. | $29.42 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831956 | CMS |
| ABBVIE INC. | $18.43 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831958 | CMS |
| ABBVIE INC. | $14.80 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103831960 | CMS |
| Integra LifeSciences Corporation | $234.13 | 01/05/2024 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 1140097392 | CMS |
| Integra LifeSciences Corporation | $87.45 | 01/24/2024 | Long term medical supply or device loan | Undisputed | 01/23/2026 | 1140097396 | CMS |
| Integra LifeSciences Corporation | $10.12 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140097400 | CMS |
| Kerecis Limited | $147.78 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120115467 | CMS |
| Mindray DS USA, Inc. | $17.65 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150671540 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.